NDC 68071-2625-06 - Diclofenac Potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-2625
- Requested NDC
- 68071-2625-06
- Package NDCs from labels
- 68071-2625-9, 68071-2625-3, 68071-2625-6, 68071-2625-06
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2026-06-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Diclofenac Potassium Tablets, USP 50 mg | NuCare Pharmaceuticals,Inc. | 2026-06-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-2625-3 | Diclofenac Potassium | 30 in 1 BOTTLE | TABLET, COATED | 30 | 3 | |
| 68071-2625-6 | Diclofenac Potassium | 60 in 1 BOTTLE | TABLET, COATED | 60 | 3 | |
| 68071-2625-9 | Diclofenac Potassium | 9 in 1 BOTTLE | TABLET, COATED | 9 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-2625 | DICLOFENAC POTASSIUM TABLET, COATED [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, Legacy NDC, 3 package rows | 20250116_d61cbb27-737d-948c-e053-2a95a90adaca.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HERA SILKYSTAY FOUNDATION 48N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4372c4-b87a-91ab-e063-6294a90a6807 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 49C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4380d1-2cf4-1fd8-e063-6394a90a0aa3 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA BLACK CUSHION FOUNDATION 13N1 | OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE | Amorepacific Corporation | 5aff3d25-d034-0815-e063-6294a90a8664 | 2026-10-29 | Warnings | 15FIX9V2JP |
| DICLOFENAC POTASSIUM | DICLOFENAC POTASSIUM | Umedica Laboratories USA Inc. | 33930285-dd97-415c-9e2a-491bd7b12af9 | 2026-10-28 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Blue Lizard Sensitive SPF 50 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | 32d78048-d281-1d80-e063-6394a90aec19 | 2026-10-28 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 32W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eed2165-afc2-6958-e063-6294a90add58 | 2026-10-28 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 34O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eedd87b-a7b1-1abc-e063-6294a90ae29e | 2026-10-28 | Warnings | 15FIX9V2JP |
| DICLOFENAC POTASSIUM | DICLOFENAC POTASSIUM | Nivagen Pharmaceuticals, Inc. | eb52a015-23cd-40f6-bf83-6749fc34947c | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM TABLETS | NIVAGEN PHARMACEUTICALS, INC. | 1f06a404-07c3-4414-8c5c-357c01d6ccb3 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 857702 L4D5UA6CB4 |
| HERA SILKYSTAY FOUNDATION 26N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7151e-4f83-4aca-e063-6294a90a9818 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 26W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7276d-fcaf-65b2-e063-6394a90ac220 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec73566-5d67-7153-e063-6394a90aba33 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec75100-153c-80cd-e063-6294a90a6d51 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec77f7a-4621-ac0c-e063-6294a90a3f70 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 29N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7ab15-9cc1-d53a-e063-6294a90a4111 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 29W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec83b87-08bc-7590-e063-6294a90a0b78 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 31C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec857a3-7fd1-6461-e063-6394a90aacd7 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 31N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec871dc-f74e-765c-e063-6394a90a27a5 | 2026-10-26 | Warnings | 15FIX9V2JP |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Ascend Laboratories, LLC | f675a627-c944-4ec6-8c08-b5fdb78dc269 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| HERA SILKYSTAY FOUNDATION 13N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb19976-6983-3d9e-e063-6394a90a01ee | 2026-10-25 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.